3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
41
Melanoma
8
Uterine Cervical Neoplasms
7
Endometrial Neoplasms
7
Mouth Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
4
Vulvar Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Uterine Neoplasms
2
Rectal Neoplasms
2
Neoplasm Micrometastasis
2
Neoplasm Metastasis
2
Lymphatic Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Head and Neck Neoplasms
2
Eccrine Porocarcinoma
2
Breast Neoplasms, Male
2
Breast Carcinoma In Situ
2
Waldenstrom Macroglobulinemia
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sentinel Lymph Node
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pediatric Patients With Solid Tumors
1
Pancreatic Neoplasms
1
Interventions
Fluorouracil
14
Radiotherapy
11
Mitomycin
9
Radiation
8
Capecitabine
8
Surveys and Questionnaires
6
Drug Therapy
6
Cisplatin
6
pembrolizumab
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Irinotecan
3
Immune Checkpoint Inhibitors
3
Cetuximab
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Therapeutics
2
Specimen Handling
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Observation
2
Nivolumab
2
Cyclophosphamide
2
Blood Specimen Collection
2
Adoptive Transfer
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anus Neoplasms
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT02162641
2015-06-03
R-SeNSAR
The Christie NHS Foundation Trust
Withdrawn